1.
Gorobets L, Litvinov A. CARIPRAZINE: NEUROENDOCRINE AND METABOLIC ASPECTS OF TOLERANCE IN PATIENTS WITH MENTAL DISORDERS. СТПР [Internet]. 2020 Sep. 30 [cited 2024 May 18];(3):19-27. Available from: https://ctmd.psypharma.ru/index.php/ctmd/article/view/64